Engineered protein that cuts Alzheimer's-linked brain deposits opens potential therapeutic avenue
A KAIST-led research team has found that a protein involved in gene regulation can suppress the harmful aggregation of amyloid-beta, a peptide associated with Alzheimer's disease. The approach also reduced the toxicity of protein aggregates that had already formed.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Hidden genetic differences in gut bacteria may hold clues to aging
United Kingdom
-
Hybrid light method reveals how camera signals can probe blood flow in deeper tissues
United Kingdom
-
Kidney care trial challenges default dialysis planning for older adults with frailty
United Kingdom
-
Two 'forever chemicals' associated with higher risk of aggressive breast cancer in analysis
United Kingdom
-
Neural signaling protein could be therapeutic target for autism-linked gene deletion
United Kingdom
-
Personalized vaccine targets melanoma recurrence
United Kingdom
-
AHA: Cannabis use linked to increased odds of atherosclerotic cardiovascular disease
United Kingdom
-
New study warns of dangers behind AI chatbots and 'concerning' health advice from private clinics
United Kingdom